nilutamide has been researched along with Menopause in 1 studies
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Millward, MJ | 1 |
| Cantwell, BM | 1 |
| Dowsett, M | 1 |
| Carmichael, J | 1 |
| Harris, AL | 1 |
1 trial available for nilutamide and Menopause
| Article | Year |
|---|---|
Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Estradiol; Female | 1991 |